600056 China Meheco Group

Watchlist

10.39
+0.04+0.39%

Market Closed Jun 25 15:00 CST

15.54BMarket Cap27.93P/E (TTM)

About China Meheco Group Company

The company is a listed company controlled by General Technology Group. Its predecessor was the China National Pharmaceutical and Health Products Import and Export Corporation established in 1983. It joined General Technology Group in 1999 and has now become the only pharmaceutical and medical device manufacturing and operation platform under the Group. At present, Chinese medicine has built an integrated industrial pattern of trade, industry, technical services, etc. with the pharmaceutical and medical device business as the engine and the pharmaceutical industry as the support. The industrial form involves the entire industrial chain of planting and processing, R&D, production, sales, logistics, import and export trade, academic promotion, and technical services. The company's main business is pharmaceutical industry business, pharmaceutical commercial business, and medical device business. The company's main products are Chinese herbal medicines, Chinese medicine tablets, traditional Chinese medicine extracts, proprietary Chinese medicine and health products, etc., chemical preparations, chemical raw materials, diagnostic drugs and reagents, medical consumables, medical devices, specialty medical products, traditional Chinese herbal medicines and tablets, formula granules, biological agents, nutritional health products, etc., medical and rehabilitation equipment, consumables, IVD, etc., and has all categories of medical devices such as implantation consumables, general consumables, diagnostic reagents, large-scale medical equipment, and chemical dangerous goods. Corporate honors: In 2018, China Pharmaceutical won the “Listed Company China Innovative Enterprise Award”, “Listed Company with Outstanding Contribution to the 40th Anniversary of China's Reform and Opening-up”, “China's Most Valuable Listed Company Award”, “China's Top 100 Listed Companies Award”, “Listed Company Most Respected by Investors”, “Golden Junma Award for Listed Companies with the Most Craftsmanship”, “Listed Company 2018 Charity Action Award for Listed Companies”, and “2024 Chinese Healthcare Industry Green and Sustainable Practitioner”.

Company Profile

Short Name-A中国医药

Symbol-A600056

Company NameChina Meheco Co.,Ltd.

Listing DateMay 15, 1997

Issue Price7.02

Shares Offered30.00M share(s)

FoundedMay 8, 1997

Listed ExchangeSH Stock Exchange

Legal Representativeguang yang

General Managerhuidong hu

Secretaryjinghua yuan

Accounting FirmGrant Thornton Certified Public Accountants (Special General Partnership)

Securities Representativefan guo

Legal CounselBeijing Jingtian Gongcheng Law Firm

Employees206

Phone010-67164267

Office Address25-28 Floor, Building 1, District 1, Courtyard 1, Xiying Street, Fengtai District, Beijing

Zip Code100073

Registered Address25-28 Floor, Building 1, District 1, Courtyard 1, Xiying Street, Fengtai District, Beijing

Fax010-67152359

Emailmeheco600056@meheco.gt.cn

Websitehttp://www.meheco.com

Business License110000011645011

BusinessLicense items: wholesale of pharmaceuticals; sale of Class II and Class III radiation devices; operation of Class III medical devices; pharmaceutical production; import and export of pharmaceuticals. (Projects requiring approval according to law can only be carried out after approval by relevant departments; specific business projects are subject to documents or licenses approved by relevant departments) General projects: Class I medical device sales; Class II medical device sales; food sales (pre-packaged food only); health food (pre-packaged) sales; sales of infant formula and other infant formula; import and export of goods; import and export; import and export; technology import and export; food import and export; bidding agency services; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; automobile sales; Chinese herbal medicine cultivation; grain sales; animal husbandry and fishery feed sales; feed raw material sales; feed additive sales; chemical product sales (excluding licensed chemical products); general cargo storage services (excluding hazardous chemicals, etc.); machinery and equipment leasing. (With the exception of projects subject to approval according to law, business activities are carried out independently on the basis of a business license) (You may not engage in business activities prohibited or restricted by national and municipal industrial policies.)

Company Executives

Name
Position
Salary

guang yang
Chairman, Directors, Nomination Committee Members, Chairman of the Strategy and ESG Committee
494.00K

xin yang
Directors
--

zhen pan
Directors, Strategy and ESG Committee Member
--

huidong hu
Directors, General Manager, Strategy and ESG Committee Member
1.82M

zhiyong li
Independent Directors, Strategy and ESG Committee Member, Chairman of the Remuneration and Assessment Committee
200.00K

ruihua wang
Independent Directors, Nomination Committee Members, Chairman of Audit and Risk Control Committee, Member of the Remuneration and Assessment Committee
91.70K

yonghong yan
Independent Directors, Member of Audit and Risk Control Committee, Chairman of the Nomination Committee
200.00K

jinghua yuan
Board Secretary
638.80K

fan guo
Securities Affairs Representative
--

yong qiang
Chairman of the Supervisory Board, Auditors
--

zhiyong liu
Auditors
--

jiaqing hong
Deputy General Manager
1.42M

heping lv
Assistant to the General Manager
1.09M

huibo zhang
Assistant to the General Manager
1.04M

jianxiong chen
Assistant to the General Manager
--

xiaohong ge
Chief Accountant
1.25M

xingbing zhou
Employee Directors, Strategy and ESG Committee Member, Member of Audit and Risk Control Committee
1.54M

jian zhang
General Counsel
1.13M

shaofeng zhang
Employee Supervisors
745.40K

lin zhang
Employee Supervisors
813.90K

The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.

No. Symbol 5D % Chg

ProShares Short VIX Short-Term Futures ETF

SVXY